Abstract
Intellectual disability is a non-specific phenotype present in a genetically heterogeneous group of disorders. It is characterized by deficits in intellectual and adaptive functioning, presenting before 18 y of age. Identifying the cause of ID is important to provide treatment where available, genetic counseling, recurrence risks and reproductive options for subsequent pregnancies. Advances in technology, especially next generation sequencing and microarrays, have greatly increased the diagnostic yield of evaluation in cases of ID. This paper describes the points in history taking and examination in the evaluation of a proband, and discusses the proper use of newer diagnostic technologies.
Similar content being viewed by others
References
Schalock RL, Luckasson RA, Shogren KA. The renaming of mental retardation: understanding the change to the term intellectual disability. Intellect Dev Disabil. 2007;45:116–24.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th Edition. Washington, DC: APA Press; 2013.
Chiurazzi P. Mental retardation: is naming the real issue? Am J Med Genet Part A. 2011;155:974–5.
Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology. 2003;60:367–80.
Szymanski L, King BH. Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry. 1999;38:5S–31S.
Schaefer GB, Bodensteiner JB. Evaluation of the child with idiopathic mental retardation. Pediatr Clin N Am. 1992;39:929–43.
van Karnebeek CD, Jansweijer MC, Leenders AG, Offringa M, Hennekam RC. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet. 2005;13:6–25.
Schieppati A, Henter J-I, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet. 2008;371:2039–41.
Lugtenberg D, Veltman JA, van Bokhoven H. High-resolution genomic microarrays for X-linked mental retardation. Genet Med. 2007;9:560–5.
Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and autism. N Engl J Med. 2012;366:733–43.
al-Qudah AA. Screening for congenital hypothyroidism in cognitively delayed children. Ann Trop Paediatr. 1998;18:285–8.
Moeschler JB, Shevell M; Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134:e903–18.
Devriendt K, Holvoet M, Fryns J. An etiological diagnostic survey in children attending a school for special education. Genet Couns. 2003;14:125.
Rauch A, Hoyer J, Guth S, et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet Part A. 2006;140A:2063–74.
Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S. Evidence report: genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77:1629–35.
Baroncini A, Rivieri F, Capucci A, et al. FISH screening for subtelomeric rearrangements in 219 patients with idiopathic mental retardation and normal karyotype. Eur J Med Genet. 2005;48:388–96.
Kolarova J, Tangen I, Bens S, et al. Array-based DNA methylation analysis in individuals with developmental delay/intellectual disability and normal molecular karyotype. Eur J Med Genet. 2015;58:419–25.
Vissers LE, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet. 2016;17:9–18.
Stevenson RE, Charles E, Schwartz R, Rogers RC. Atlas of X-linked intellectual disability syndromes. New York: Oxford University Press; 2012.
Coffee B, Keith K, Albizua I, et al. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet. 2009;85:503–14.
Hersh JH, Saul RA; Committee on Genetics. Health supervision for children with fragile X syndrome. Pediatrics. 2011;127:994–1006.
Rauch A, Wieczorek D, Graf E, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet. 2012;380:1674–82.
de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367:1921–9.
Schuurs-Hoeijmakers JH, Vulto-van Silfhout AT, Vissers LE, et al. Identification of pathogenic gene variants in small families with intellectually disabled siblings by exome sequencing. J Med Genet. 2013;50:802–11.
Musante L, Ropers HH. Genetics of recessive cognitive disorders. Trends Genet. 2014;30:32–9.
van Karnebeek CD, Shevell M, Zschocke J, Moeschler JB, Stockler S. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. Mol Genet Metab. 2014;111:428–38.
Engbers HM, Berger R, van Hasselt P, et al. Yield of additional metabolic studies in neurodevelopmental disorders. Ann Neurol. 2008;64:212–7.
Khadilkar V, Yadav S, Agrawal KK, et al; Indian Academy of Pediatrics Growth Charts Committee. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr. 2015;52:47–55.
Hunter AG. Medical genetics: 2. The diagnostic approach to the child with dysmorphic signs. CMAJ. 2002;167:367–72.
Srour M, Mazer B, Shevell M. Analysis of clinical features predicting etiologic yield in the assessment of global developmental delay. Pediatrics. 2006;118:139–45.
Ali AS, Syed NP, Murthy GS, et al. Magnetic resonance imaging (MRI) evaluation of developmental delay in pediatric patients. J Clin Diagn Res. 2015;9:TC21–4.
Bouhadiba Z, Dacher J, Monroc M, Vanhulle C, Ménard JF, Kalifa G. MRI of the brain in the evaluation of children with developmental delay. J Radiol. 2000;81:870.
Martin E, Keller M, Ritter S, Largo RH, Thiel T, Loenneker T. Contribution of proton magnetic resonance spectroscopy to the evaluation of children with unexplained developmental delay. Pediatr Res. 2005;58:754–60.
Verbruggen KT, Meiners LC, Sijens PE, Lunsing RJ, van Spronsen FJ, Brouwer OF. Magnetic resonance imaging and proton magnetic resonance spectroscopy of the brain in the diagnostic evaluation of developmental delay. Eur J Paediatr Neurol. 2009;13:181–90.
Rauch A, Hoyer J, Guth S, et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A. 2006;140:2063–74.
Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev. 2007;17:182–92.
Ciccone R, Giorda R, Gregato G, et al. Reciprocal translocations: a trap for cytogenetists? Hum Genet. 2005;117:571–82.
Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–64.
Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST; Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13:680–685.
DECIPHER. Available at: https://decipher.sanger.ac.uk/syndromes. Accessed on 10.7.2016.
Hochstenbach R, van Binsbergen E, Engelen J, et al. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet. 2009;52:161–9.
Kleefstra T, Yntema HG, Nillesen WM, et al. MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur J Hum Genet. 2004;12:24–8.
Donzel-Javouhey A, Thauvin-Robinet C, Cusin V, et al. A new cohort of MECP2 mutation screening in unexplained mental retardation: careful re-evaluation is the best indicator for molecular diagnosis. Am J Med Genet A. 2006;140:1603–7.
Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502–11.
Thevenon J, Duffourd Y, Masurel-Paulet A, et al. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet. 2016;89:700–7.
Redin C, Gérard B, Lauer J, et al. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. J Med Genet. 2014;51:724–36.
Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344–7.
Contributions
MT: Manuscript preparation; ICV: Editing and scientific advisor; RDP: Manuscript preparation, editing and will act as guarantor for this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s12098-016-2252-6.
Rights and permissions
About this article
Cite this article
Puri, R.D., Tuteja, M. & Verma, I.C. Genetic Approach to Diagnosis of Intellectual Disability. Indian J Pediatr 83, 1141–1149 (2016). https://doi.org/10.1007/s12098-016-2205-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-016-2205-0